Gynecology and Reproductive Endocrinology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Perspective - Gynecology and Reproductive Endocrinology (2023) Volume 7, Issue 6

Management dilemmas in young women with preeclampsia: Navigating maternal and fetal well-being

Mariana Srii *

Department of Obstetrics and Gynecology, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway

*Corresponding Author:
Mariana Srii
Department of Obstetrics and Gynecology
Levanger Hospital, Nord-Trøndelag Hospital Trust
Levanger, Norway

Received: 23-Oct-2023, Manuscript No. AAGGS-23-120130; Editor assigned: 25-Oct-2023, PreQC No. AAGGS-23-120130(PQ); Reviewed:03-Nov-2023, QC No. AAGGS-23-120130; Revised:08-Nov-2023, Manuscript No. AAGGS-23-120130(R); Published: 16-Nov-2023, DOI: 10.35841/2591-7994-7.6.172

Citation: Srii M. Management dilemmas in young women with preeclampsia: Navigating maternal and fetal well-being. Gynecol Reprod Endocrinol.2023;7(6):173

Visit for more related articles at Gynecology and Reproductive Endocrinology


Preeclampsia, a hypertensive disorder occurring during pregnancy, presents unique challenges when it manifests in young women. Defined by elevated blood pressure and organ dysfunction, preeclampsia's occurrence in this demographic introduces management dilemmas that necessitate careful navigation to optimize both maternal and fetal well-being. Young women facing preeclampsia pose distinctive challenges due to their physiologic immaturity, potential lack of pre-existing health conditions, and the impact on fetal development. The delicate balance between managing maternal complications and safeguarding the developing fetus requires a nuanced approach. One of the primary management dilemmas is the optimal timing of delivery. While delivery is the only definitive cure for preeclampsia, premature birth poses risks to the developing fetus [1].

Striking the right balance becomes critical. Clinicians often face the dilemma of determining the gestational age at which the benefits of early delivery outweigh the risks of prematurity. In young women, this decision is complicated by the potential impact on the mother's long-term health and the infant's developmental outcomes. Another significant consideration is the choice between conservative management and early delivery. In some cases, initiating delivery may be the most prudent course of action to prevent further maternal deterioration. However, the challenge arises in identifying young women who may benefit from a more conservative approach, allowing for fetal maturation while closely monitoring maternal well-being. Striking this delicate balance requires a comprehensive understanding of the individual patient's health status, gestational age, and the severity of preeclampsia [2].

Maternal complications, such as HELLP syndrome (Hemolysis, Elevated Liver enzymes, and Low Platelet count), add an additional layer of complexity to the management of young women with preeclampsia. The rapid progression of these complications may necessitate emergent delivery to avert life-threatening consequences for both the mother and the fetus. However, identifying the optimal timing for intervention becomes a critical decision point, requiring close monitoring and swift action [3, 4].

The role of medical management, particularly antihypertensive medications, introduces further dilemmas. While controlling blood pressure is crucial to prevent maternal complications, certain medications may have implications for fetal well-being. Balancing the need for maternal stability with the potential impact on the developing fetus becomes a pivotal consideration in the management of young women with preeclampsia [5].

Additionally, the psychological impact on young mothers facing a high-risk pregnancy cannot be overlooked. The emotional stress and uncertainty surrounding preeclampsia may influence decision-making, compliance with medical recommendations, and overall maternal well-being. An integrated approach that addresses both the physical and emotional aspects of care is essential for optimizing outcomes in this population. Navigating these management dilemmas requires a multidisciplinary approach involving obstetricians, neonatologists, maternal-fetal medicine specialists, and mental health professionals. Regular and clear communication with the patient and her family is paramount, ensuring that they are well-informed participants in the decision-making process.


In conclusion, managing preeclampsia in young women involves a delicate dance between ensuring maternal well-being and promoting fetal development. The complexity of this task is compounded by the unique physiological considerations of young mothers and the potential long-term consequences for both the mother and the infant. A personalized and multidisciplinary approach is essential to navigate the myriad dilemmas inherent in the management of preeclampsia in this specific demographic, ultimately striving for the best possible outcomes for both maternal and fetal health.


  1. Sorouri K, Loren AW, Amant F, Partridge AH. Patient-Centered Care in the Management of Cancer During Pregnancy. Am Soc Clin Oncol Educ Book. 2023;43:100037.

Indexed at, Google Scholar, Cross ref

  1. Neonatol JP. Maternal Use of Marijuana during Pregnancy and Lactation: Implications for Infant and Child Development and Their Well-Being.

Indexed at, Google Scholar, Cross ref

  1. Orakzai ZJ, Noureen S, Ahmad R, et al. The Role of Diagnostic Radiology in Pregnancy Induced Gynecological Complications. A Clinical Based Comparative Study. Pakistan J Medical Health Sci. 2023;17(03):409.

Indexed at, Google Scholar, Cross ref

  1. Choi R, Nagappan A, Kopyto D, et al. Pregnant at the start of the pandemic: a content analysis of COVID-19-related posts on online pregnancy discussion boards. BMC. 2022;22(1):493.

Indexed at, Google Scholar, Cross ref

  1. Kostro M, Jacyna N, G?uszczak-Idziakowska E, et al. Factors affecting the differentiation of the apgar score and the biochemical correlation of fetal well-being–A prospective observational clinical study. J Mother Child. 2021;22(3):238-46.

Indexed at, Google Scholar, Cross ref

  1. O'neill E, Thorp J. Antepartum evaluation of the fetus and fetal wellbeing. Clin Obstet Gynecol. 2012;55(3):722.

Indexed at, Google Scholar, Cross ref

  1. Buczinski S, Fecteau G, Lefebvre RC, et al. Assessment of fetal well-being in cattle by ultrasonography in normal, high-risk, and cloned pregnancies. Can Vet J. 2011;52(2):136.

Indexed at, Google Scholar

  1. Brunelli R, Masselli G, Parasassi T, et al. Intervillous circulation in intra-uterine growth restriction. Correlation to fetal wellbeing. Placenta. 2010;31(12):1051-6.

Indexed at, Google Scholar, Cross ref

  1. Arulkumarany S, Ingemarsson I, Ratnam SS. Fetal Heart Rate Response to Scalp Stimulation as a Test of Fetal Well?Being in Labour. J Obstet Gynaecol Res. 1987;13(2):131-5.

Indexed at, Google Scholar, Cross ref

  1. Reef VB, Vaala WE, Worth LT, et al. Ultrasonographic assessment of fetal well?being during late gestation: development of an equine biophysical profile. Equine Vet J. 1996;28(3):200-8.

Indexed at, Google Scholar, Cross ref

Get the App